LegoChem Biosciences, Inc   Report issue

For profit Phase 2
Founded: Daejeon Korea, Republic of (2006)

Organization Overview

First Clinical Trial
2012
NCT01554995
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

LegoChem Biosciences, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 13
  • # of Trial APIs: 7